A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
Introduction
Epidemiological studies have identified low circulating levels of high density lipoprotein (HDL) as a strong, independent risk factor for premature atherosclerosis and coronary heart disease (CHD) [1], [2]. Low HDL states are the most common form of dyslipidemia in CHD patients [3]. Genetic deficiency of apolipoprotein A-I (apoA-I) [4], a major HDL apolipoprotein, or elevated activities of plasma cholesteryl ester transfer protein (CETP) and/or hepatic lipase (HL) [5], or reduced activities of lecithin-cholesterol acyltransferase (LCAT) [6] or lipoprotein lipase (LPL) [7], may equally underlie a low HDL-C phenotype.
In contrast to low HDL-C phenotypes, elevated HDL levels are frequently associated with low cardiovascular (CV) risk [1], [2]. Indeed, plasma HDL particles exert potent antiatherogenic and anti-inflammatory activities, including antioxidative activity, which endows them with the capacity to protect low density lipoprotein (LDL) against oxidative stress [8]. In vivo, endothelial dysfunction and local inflammation in the arterial wall give rise to the production of a spectrum of prooxidants which act to oxidise LDL [9]. However, HDL particles transport enzymes exerting antioxidative activity, including paraoxonase (PON) [10], platelet-activating factor acetylhydrolase (PAF-AH) [11] and LCAT [12], which may inhibit LDL oxidation. These enzymes hydrolyse diverse molecular species of oxidised lipids, preventing their accumulation in LDL. ApoA-I inhibits LDL oxidation by removing oxidised lipids from LDL [13]; in addition, the intrinsic physicochemical properties of HDL particles can contribute to HDL antioxidative activity [14].
Plasma HDL particles are highly heterogeneous in their structure, metabolism and biological function. Small, dense HDL3 possess higher capacities to accept cholesterol [15], to inhibit expression of adhesion molecules [16] and to exert protection of LDL from oxidation [14] as compared to large, light HDL2. Indeed, specific association was observed between elevated plasma levels of HDL3 and diminished CV risk in the VA-HIT trial [17].
The physicochemical properties and biological activity of HDL particle subfractions may be altered in low HDL-C dyslipidemias; for example, in hypertriglyceridemia associated with low HDL-C levels, small, triglyceride (TG)-rich HDL particles accumulate and display diminished capacity for cellular cholesterol efflux [18] together with a reduced plasma residence time [19]. Similarly, HDL are defective acceptors of cellular cholesterol in familial HDL deficiency [20]. Moreover, in double apoA-I- and LDL receptor-deficient mice, low HDL-C levels result in markedly increased atherosclerosis and elevated oxidative stress [21], strongly indicating a link between oxidative stress and HDL functionality. These studies provoke the working hypothesis that HDL antioxidative function may be attenuated in human dyslipidemias involving low HDL-C levels and oxidative stress.
The potential relationships between oxidative stress and the antioxidative function of HDL particles is however indeterminate in low HDL-C dyslipidemias. We, therefore, evaluated the relationship of systemic oxidative stress to the capacity of HDL particle subfractions to protect LDL from oxidation in normocholesterolemic, normotriglyceridemic, normoglycemic subjects displaying low HDL-C levels. Our data reveal that the intrinsic antioxidative activity of HDL subfractions is deficient in this low HDL-C phenotype, that this deficient activity is amplified by subnormal numbers of circulating HDL particles and that this HDL dysfunctionality is intimately related to elevated oxidative stress monitored as breakdown products of arachidonic acid, i.e. plasma 8-isoprostanes [22].
Section snippets
Subjects
Low HDL-C male subjects (n = 8) were recruited at the Campinas University Hospital (Campinas, Brazil); normolipidemic control male subjects were recruited at the Campinas University Hospital (n = 12) and Hôpital La Pitié (Paris, France; n = 3). No significant differences were found in physico-chemical properties of HDL subfractions between Brazilian and French controls (data not shown) who were therefore combined in a single control group (n = 15). Subjects displaying a low HDL-C phenotype were
Clinical and biological parameters
Plasma levels of both HDL-C and apoA-I were significantly lower (−40 and −31%, respectively) in low HDL-C subjects (n = 8) in comparison with the normolipidemic control group (n = 15; Table 1). In contrast, no significant difference in plasma levels of TG, TC, LDL-C and apoB100 was found between low HDL-C and normolipidemic control groups. Nonetheless, the TC/HDL-C ratio was significantly higher in low HDL-C subjects than in controls (Table 1). There was no significant difference in age, body mass
Discussion
These studies have confirmed our working hypothesis that elevated oxidative stress is associated with HDL subfractions displaying attenuated antioxidative activity in subjects presenting low HDL-C dyslipidemia. Indeed, using an integrated experimental approach, we presently demonstrate for the first time that the major particle subfractions of HDL (HDL2b, 2a, 3a, 3b and 3c) in a distinct and rigorously defined normotriglyceridemic, normocholesterolemic, normoglycemic low HDL-C phenotype are
Acknowledgements
These studies were supported by National Institute for Health and Medical Research (INSERM), Association Claude Bernard and Association for Research on Lipoproteins and Atherogenesis (ARLA), France. Dr. A. Kontush gratefully acknowledges the award of an INSERM ‘Poste Orange’ Fellowship for Senior Investigators, and of Research Fellowships from Fondation pour la Recherche Medicale (FRM) and the French Atherosclerosis Society in partnership with AstraZeneca. We thank Dr. M. Guerin for fruitful
References (42)
- et al.
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes
J Lipid Res
(1997) - et al.
The role of high-density lipoproteins in oxidation and inflammation
Trends Cardiovasc Med
(2001) - et al.
Novel function of lecithin-cholesterol acyltransferase
J. Biol. Chem.
(1997) - et al.
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
J Lipid Res
(2000) - et al.
Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels
Atherosclerosis
(2000) - et al.
Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys
J Lipid Res
(1994) - et al.
Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo
Free Radic Biol Med
(2000) - et al.
Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry
Anal Biochem
(1999) - et al.
A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
J. Lipid Res.
(1981) - et al.
Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein partial purification of a transfer-stimulating plasma factor using a rapid transfer assay
Biochim Biophys Acta
(1982)
Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans
Free Radic Biol Med
Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age
Free Radic Biol Med
Apolipoprotein A-I: structure–function relationships
J Lipid Res
Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids
Biochim Biophys Acta
Copper oxidation of in vitro dioleolylphosphatidylcholine-enriched high-density lipoproteins: physicochemical features and cholesterol effluxing capacity
Arch Biochem Biophys
Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein
J Lipid Res
Effects of acceptor particle size on the efflux of cellular free cholesterol
J Biol Chem
Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter
Am J Cardiol
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid—a position paper developed by the European Consensus Panel on HDL-C
Curr Med Res Opin
Apolipoprotein A-I deficiency biochemical and metabolic characteristics
Arterioscler Thromb Vasc Biol
Cited by (113)
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia
2023, Journal of Clinical LipidologyElevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis
2022, Nutrition, Metabolism and Cardiovascular DiseasesHigh density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?
2021, Vascular PharmacologyGenetic polymorphism of interleukin-16 and its association with the clinical and radiographic severity in primary knee osteoarthritis patients
2021, Egyptian RheumatologistCitation Excerpt :Dyslipidemia may affect the homeostasis of the human body's internal environment and then cause its own immune regulation. Dyslipidemia is related to chronic low-grade inflammation and oxidative stress, likely increasing the development of OA [30,31]. In this work patients had significantly higher BMI and higher TG, cholesterol and LDL levels compared to controls, which was in agreement to Fadda and colleagues [2].
Changes in redox and endoplasmic reticulum homeostasis are related to congenital generalized lipodystrophy type 2
2020, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids